Skip to content

mustadikwath in diabetes

clinical study to evaluate the effect of mustadikwath in madhumeha

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024884
Enrollment
40
Registered
2020-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: clinical study to evaluate the effect of mustadi kwath in madhumeha: musta, amalki, haritki, vibhitak, indrayan root, haridra, devdaru, murwa, lodhra Intervention2: Nil: nil Interventio

Sponsors

geetika
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: fasting blood sugar level >110mg/dl- post prandial blood sugar level >140mg/dl- patient between age group of 30-60 year

Exclusion criteria

Exclusion criteria: patient of type 1 diabetes age below 30 years and above 60 year blood sugar fasting level > 350mg/dl post prandial blood sugar level > 450mg/dl patient having complication and suffering from any serious medical or surgical illnes personal matter

Design outcomes

Primary

MeasureTime frame
reduction of symptoms like excessive urination, turbidity in urine, excessive hunger excessive thirst,burning sensation of hands and feets, weaknessTimepoint: The patient will be followed up at 7th day and 14th after completion of trail.

Secondary

MeasureTime frame
reduction in symptoms like excessive hunger , excessive urination, turbidity in urine, excessive thirst, burning sensation of hand and feet , weaknessTimepoint: The patient will be followed up at 7th day and 14th after completion of trail.

Countries

India

Contacts

Public ContactGeetika

gurukul university

pandey.punita62@gmail.com9084394202

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026